MARK4 Antibody
-
中文名稱：MARK4兔多克隆抗體
-
貨號：CSB-PA219664
-
規格：￥1100
-
圖片：
-
The image on the left is immunohistochemistry of paraffin-embedded Human gastic cancer tissue using CSB-PA219664(MARK4 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)
-
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：MARK4
-
別名：FLJ90097 antibody; KIAA1860 antibody; MAP / microtubule affinity regulating kinase 4 antibody; MAP / microtubule affinity regulating kinase 4L antibody; MAP/microtubule affinity regulating kinase 4 antibody; MAP/microtubule affinity regulating kinase like 1 antibody; MAP/microtubule affinity-regulating kinase 4 antibody; MAP/microtubule affinity-regulating kinase-like 1 antibody; MARK 4 antibody; MARK 4L antibody; MARK L1 antibody; MARK4 antibody; MARK4 serine / threonine protein kinase antibody; MARK4 serine/threonine protein kinase antibody; MARK4_HUMAN antibody; MARK4S antibody; MARKL 1 antibody; MARKL1 antibody; Nbla00650 antibody; Putative protein product of Nbla00650 antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse
-
免疫原：Synthetic peptide of Human MARK4
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：Antigen affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
產品提供形式：Liquid
-
應用范圍：ELISA,IHC
-
推薦稀釋比：
Application Recommended Dilution ELISA 1:1000-1:2000 IHC 1:25-1:100 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Serine/threonine-protein kinase. Phosphorylates the microtubule-associated protein MAPT/TAU. Also phosphorylates the microtubule-associated proteins MAP2 and MAP4. Involved in regulation of the microtubule network, causing reorganization of microtubules into bundles. Required for the initiation of axoneme extension during cilium assembly. Regulates the centrosomal location of ODF2 and phosphorylates ODF2 in vitro. Plays a role in cell cycle progression, specifically in the G1/S checkpoint. Reduces neuronal cell survival. Plays a role in energy homeostasis by regulating satiety and metabolic rate. Promotes adipogenesis by activating JNK1 and inhibiting the p38MAPK pathway, and triggers apoptosis by activating the JNK1 pathway. Phosphorylates mTORC1 complex member RPTOR and acts as a negative regulator of the mTORC1 complex, probably due to disruption of the interaction between phosphorylated RPTOR and the RRAGA/RRAGC heterodimer which is required for mTORC1 activation.
-
基因功能參考文獻：
- data demonstrate that miR-515-5p dramatically inhibits cell migration by directly down-regulating MARK4 expression in two different cancer types PMID: 26882547
- Our results show that MARK4 acts as a negative regulator of the Hippo kinase cassette to promote YAP/TAZ activity and that loss of MARK4 restrains the tumorigenic properties of breast cancer cells. PMID: 28183853
- Atypical PKC phosphorylates serine-threonine residues of MARK4. PMID: 26346160
- Suggest role for polypyrimidine-tract binding protein in regulating alternative splicing of MARK4 in gliomas. PMID: 25578778
- MARK4 is a key component in the regulation of microtubule dynamics and has major role in cell cycle progression, particularly at the G1/S transition. PMID: 25123532
- Molecular dynamic simulation data predicted the three dimensional structure for the kinase domain of MARK4 and its structural properties. PMID: 24763618
- A strong and significant elevation of MARK4 expression and MARK4-tau interactions in AD brains correlates with the Braak stages of the disease, suggesting that the MARK4-tau interactions are of functional importance in the progression of AD. PMID: 23666762
- MARK4 is a critical positive regulator of early steps in ciliogenesis. PMID: 23400999
- MARK4 is a new negative regulator of mTORC1 PMID: 23184942
- The balance between the MARK4 isoforms is carefully guarded during neural differentiation but may be subverted in gliomagenesis. PMID: 22156016
- Even though an association of the polymorphisms rs2850328 and rs2395 and breast cancer was not detected in our case-control study population, other variants within the PPP3CA and MARK4 genes may still be associated with breast cancer. PMID: 22506312
- Observational study, meta-analysis, and genome-wide association study of gene-disease association and gene-gene interaction. (HuGE Navigator) PMID: 20460622
- demonstrated that the endogenous MARK4L colocalizes with centrosomes at all mitotic stages and resides in centrosome-enriched fractions. PMID: 19759416
- Normally expressed in neural progenitors, re-expressed in gliomas and may become a target of amplification upon chr. 19 rearrangement. PMID: 12735302
- MARK4 is likely to be directly involved in microtubule organization in neuronal cells PMID: 14594945
- NUAK1 and MARK4 are substrates of USP9X PMID: 18254724
顯示更多
收起更多
-
亞細胞定位：Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, microtubule organizing center. Cytoplasm, cytoskeleton, cilium basal body. Cytoplasm, cytoskeleton, cilium axoneme. Cytoplasm. Cell projection, dendrite.
-
蛋白家族：Protein kinase superfamily, CAMK Ser/Thr protein kinase family, SNF1 subfamily
-
組織特異性：Ubiquitous. Isoform 2 is brain-specific. Expressed at highest levels in brain and testis. Also expressed in heart, lung, liver, muscle, kidney and spleen.
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
